Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

COVID: Italy's drugs chief airs 'grave concern' on Pfizer jab delay

COVID: Italy's drugs chief airs 'grave concern' on Pfizer jab delay

Magrini also says 'prudent' on OK for AstraZeneca vaccine

ROME, 19 January 2021, 13:47

Redazione ANSA

ANSACheck

© ANSA/EPA

© ANSA/EPA
© ANSA/EPA

The head of Italian drugs agency AIFA on Tuesday voiced "grace concern" over delays in the delivery of the Pfizer COVID-19 vaccine to Italy.
    "Pfizer delay very concerning. It was all communicated at the last minute, and if it's just a week's delay the consequences may not be so serious," said AIFA Director-General Nicola Magrini.
    "We can define it as a small slowdown.
    "The objective is to vaccinate all the over-80s and health workers in March.
    "I'm sure we'll succeed." Asked about the possibility of the AstraZeneca vaccine being approved at the end of January, Magrini said "I am prudent, I don't base my views on promises".
    Italy is moving ahead with second vaccinations but many regions have said they will put new first vaccinations on hold following Pfizer's announcement of a delay in delivery of the doses.
    Pfizer said last week that upgrades at its Belgian production plant would hinder distribution.
    But it said it expects to get things moving at their former pace from January 25.
   

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.